Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Objective: To report nationally representative findings on the prevalence, correlates, psychiatric comorbidity and treatment of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia. Method: The 2007 National Survey of Mental Health and Wellbeing was a nationally representative household survey of 8841 Australians (16–85 years) that assessed symptoms of the most prevalent DSM-IV mental disorders. Results: Prevalence of lifetime and 12-month cannabis use was 18% and 6%; prevalence of lifetime and 12-month cannabis use disorder was 6% and 1%. The conditional prevalence (proportion of ever users who met criteria for a disorder) of lifetime and 12-month cannabis use disorder was 32.2% and 14.3%. Current cannabis use disorders were more common in males (OR 2.0) and younger users (OR 4.6). Strong associations were observed between current cannabis use disorders and alcohol use disorders (OR 3.6) and current affective disorders (OR 3.0). Only 36.2% of those with current cannabis use disorders sought any treatment. Conclusions: The prevalence of cannabis use disorders in the Australian population is comparable with that in the USA. Current cannabis use disorders are highly concentrated in young Australians who have high levels of comorbidity. The low rates of treatment seeking warrant attention in treatment and prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“over 40% of individuals with CUD have a comorbid anxiety disorder (Teesson et al., 2012).”
From Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial (2019) · cites this paper as Teesson et al., 2012
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“The rates of use reported herein are similar to those reported in European countries, particularly France (19.0), Germany (17.5) and the Netherlands (19.8) (Degenhardt et al., 2008, Kessler and Ustun, 2004, Kessler et al., 2005, Wells et al., 2006).”
InfluentialKessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771 · cited 4×
“The rates of use reported herein are similar to those reported in European countries, particularly France (19.0), Germany (17.5) and the Netherlands (19.8) (Degenhardt et al., 2008, Kessler and Ustun, 2004, Kessler et al., 2005, Wells et al., 2006).”
InfluentialHasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908 · cited 2×
“It is crucial that epidemiological information be as upto-date and accurate as possible to reflect dynamic changes in patterns of drug use (Hasin et al., 2007).”
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.566 · Cited by 1,152 · cited 5×
“…NSW 2052, Australia Email: m.teesson@unsw.edu.au Australian & New Zealand Journal of Psychiatry, 46(12) the prevalence of cannabis use disorders in the past year has ranged from 1.4% in New Zealand to 2.2% in the Australian population(Compton et al., 2007; Swift et al., 2001; Wells et al., 2006).”
InfluentialAdverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Self-citation2007 National Survey of Mental Health and Wellbeing: Methods and Key Findings
Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902970882 · Cited by 832 · cited 4×
“The youngest (16–24 years) and oldest (65–85 years) age groups had a higher probability of being selected to ensure sufficient samples sizes (Slade et al., 2009).”
InfluentialSelf-citationPrevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004) · JAMA · doi:10.1001/jama.291.17.2114 · Cited by 537
Cannabis use and later life outcomes
Fergusson, D. M., & Boden, J. M. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02221.x · Cited by 526 · cited 2×
“This could be because people with cannabis use disorders find it difficult to find employment or, alternatively, because those who become unemployed or who leave the labour force may be more likely to use cannabis, and, hence, are at increased risk of a cannabis use disorder (Fergusson and Boden, 2008).”
Collins, D. J., & Lapsley, H. M. (2008) · PsycEXTRA Dataset · doi:10.1037/e674312010-001 · Cited by 425
Substance use, abuse and dependence in adolescence: prevalence, symptom profiles and correlates
Young, S. E., Corley, R. P., Stallings, M. C., Rhee, S. H., Crowley, T. J., & Hewitt, J. K. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00225-9 · Cited by 341 · cited 1×
“It may also be a ‘diagnostic bias’, with younger age groups more frequently endorsing cannabis use disorder criteria, although there is little support to date for this hypothesis (Young et al., 2002).”
Background
Research works printed but not linked: 1
- United Nations Office on Drugs and Crime, 2009, World Drug Report
Cited by
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070907 · Cited by 579
“The prevalence and odds of 12-month and lifetime cannabis use disorders were greater among men than women, consistent with earlier surveys (17, 50, 51).”
ResultCannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Self-citationHunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.141 · Cited by 289
Psychosocial interventions for cannabis use disorder
Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005336.pub4 · Cited by 282
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Swift, W., Wong, A., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 182
“Globally, Australia has one of the highest rates of cannabis use [26,27], while the occurrence of population indicators of cannabisrelated harm, including hospital separations for cannabis-induced psychosis and cannabis-related problems such as dependence, increased over the 2000s [28].”
BackgroundSelf-citation
Metadata
- Authors
- Teesson, M., Slade, T., Swift, W., Mills, K., Memedovic, S., Mewton, L., Grove, R., Newton, N., & Hall, W.
- Affiliations
- UNSW Sydney (AU)
- The University of Queensland (AU)
- ORCID
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2012-09-14
- Volume
- 46
- Issue
- 12
- Pages
- 1182-1192
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W1989744420
- Cited by
- 72
- References
- 35
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 11 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 2 · 2014: 2 · 2013: 6 · 2012: 1
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- cannabis use disorder, cannabis use prevalence, psychiatric comorbidity, alcoholism, mood disorders, treatment seeking, DSM-IV, Australia
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, 80 and over, Alcohol Drinking, Australia, Cannabis, Marijuana Abuse, Demography, Female, Health Surveys, Humans, Male, Patient Acceptance of Health Care, Psychiatric Status Rating Scales, Risk Factors, Sex Factors, Socioeconomic Factors, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia. https://app.cochat.ai/papers/10.1177/0004867412460591
- The paper
- Teesson, M., Slade, T., Swift, W., Mills, K., Memedovic, S., Mewton, L., Grove, R., Newton, N., & Hall, W. (2012). Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867412460591
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.